NO975962L - Legemiddelpreparat som omfatter albumin som aktiv bestanddel - Google Patents

Legemiddelpreparat som omfatter albumin som aktiv bestanddel

Info

Publication number
NO975962L
NO975962L NO975962A NO975962A NO975962L NO 975962 L NO975962 L NO 975962L NO 975962 A NO975962 A NO 975962A NO 975962 A NO975962 A NO 975962A NO 975962 L NO975962 L NO 975962L
Authority
NO
Norway
Prior art keywords
albumin
present
active ingredient
treatment
pharmaceutical composition
Prior art date
Application number
NO975962A
Other languages
English (en)
Other versions
NO320601B1 (no
NO975962D0 (no
Inventor
Kazuo Tsubota
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of NO975962D0 publication Critical patent/NO975962D0/no
Publication of NO975962L publication Critical patent/NO975962L/no
Publication of NO320601B1 publication Critical patent/NO320601B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19975962A 1996-04-19 1997-12-18 Anvendelse av albumin til fremstilling av farmasoytiske preparater NO320601B1 (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP9809096 1996-04-19
JP10686696 1996-04-26
US75294196A 1996-11-21 1996-11-21
US75292896A 1996-11-21 1996-11-21
PCT/JP1997/001329 WO1997039769A1 (fr) 1996-04-19 1997-04-17 Composition de medicament comprenant de l'albumine en tant que principe actif

Publications (3)

Publication Number Publication Date
NO975962D0 NO975962D0 (no) 1997-12-18
NO975962L true NO975962L (no) 1998-02-18
NO320601B1 NO320601B1 (no) 2005-12-27

Family

ID=27468604

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19975962A NO320601B1 (no) 1996-04-19 1997-12-18 Anvendelse av albumin til fremstilling av farmasoytiske preparater

Country Status (11)

Country Link
US (2) US6043213A (no)
EP (1) EP0834320B1 (no)
JP (1) JP3058920B2 (no)
KR (1) KR100455475B1 (no)
CN (1) CN1124158C (no)
AT (1) ATE274918T1 (no)
CA (1) CA2225398C (no)
DE (1) DE69730476T2 (no)
ES (1) ES2227684T3 (no)
NO (1) NO320601B1 (no)
WO (1) WO1997039769A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6815419B1 (en) 1999-07-28 2004-11-09 Morinaga Milk Industry Co., Ltd. Antiulcer agent
GB0019378D0 (en) * 2000-08-07 2000-09-27 Saugstad Ola D Method
DE60224857T2 (de) * 2001-04-26 2009-02-05 R-Tech Ueno, Ltd. Verwendung von Albumin in Kombination mit Wachstumsfaktoren zur Inhibierung von Apoptose
US20030211043A1 (en) * 2001-09-28 2003-11-13 Korb Donald R. Eye treatment
US20060234907A1 (en) * 2004-02-13 2006-10-19 Werner Gehringer Albumin solution and process for the production thereof
US8455016B2 (en) 2004-03-12 2013-06-04 Melbj Holdings, Llc Treatment for meibomian gland dysfunction or obstruction
US20050202097A1 (en) * 2004-03-12 2005-09-15 Melbj Holdings, Llc, Florida Lubricant for the ocular surface
US7189697B2 (en) * 2004-04-13 2007-03-13 Trustees Of Tufts College Compositions and uses of a galectin for treatment of dry eye syndrome
US20060232060A1 (en) * 2005-04-13 2006-10-19 Assignee1 Pressure sensitive packing laminate overlay form combination and method of using same
WO2007033020A2 (en) * 2005-09-13 2007-03-22 Bausch & Lomb Incorporated Ophthalmic formulation for treatment of dry eye
US20080286211A1 (en) * 2007-04-27 2008-11-20 Barker Nicholas P Using mucin glycoproteins in combination with therapeutic agents to treat epithelial lesions and disorders of impaired mucin function
US20110065642A1 (en) 2008-05-15 2011-03-17 R-Tech Ueno, Ltd. Pharmaceutical composition for the treatment of dry eye and/or corneal and conjunctival lesion
KR101422571B1 (ko) 2009-10-13 2014-07-24 삼성전자 주식회사 받침대 및 이를 구비한 세탁기
AU2013203609B2 (en) * 2009-11-27 2014-08-21 R-Tech Ueno, Ltd. Method for screening drug efficacious in treating dry eye and/or keratoconjunctival disorders and pharmaceutical composition obtained thereby
BR112012012767A2 (pt) * 2009-11-27 2016-09-06 R Tech Ueno Ltd método para avaliar um agente que é útil para o tratamento de olho seco e/ou lesão corneana e conjutiva e uma composição farmacêutica obtida pelo método
AU2011347237A1 (en) * 2010-12-21 2013-07-11 Recopharma Ab Tear substitutes
DE102015205293A1 (de) 2015-03-24 2016-09-29 Marc Schrott Verfahren zur Herstellung von Augentropfen
KR102368465B1 (ko) * 2016-04-01 2022-03-02 주식회사 바이오코즈글로벌코리아 세포배양배지에 알부민, 히알루론산, 또는 콜라겐을 유효성분으로 포함하는 화장용 조성물
CA3092234A1 (en) 2018-03-09 2019-09-12 Panoptes Pharma Ges.M.B.H. Ophthalmic formulation
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
BR112021000724A2 (pt) 2018-07-27 2021-04-13 Johnson & Johnson Surgical Vision, Inc. Composições e métodos para tratar os olhos
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
WO2024018452A1 (en) 2022-07-18 2024-01-25 Yeda Research And Development Co. Ltd. Albumin protein variants, production thereof and uses of same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57126422A (en) * 1981-01-29 1982-08-06 Green Cross Corp:The Stabilizing method of lysozyme pharmaceutical
JPS61103836A (ja) * 1984-10-24 1986-05-22 Green Cross Corp:The フイブロネクチン製剤
CA1263606A (en) * 1985-05-29 1989-12-05 Jeffrey P. Gilbard Non-toxic opthalmic preparations
JPS6391331A (ja) * 1986-10-03 1988-04-22 Senjiyu Seiyaku Kk 眼科用水性組成物
WO1990011781A1 (en) * 1989-04-04 1990-10-18 Alcon Laboratories, Inc. The use of liposomes for the delivery of therapeutic agents to wounds, cuts and abrasions
US5174988A (en) * 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
JPH05310592A (ja) * 1992-05-11 1993-11-22 Nichirei Corp 創傷治療剤及び医薬製剤
JPH06271478A (ja) * 1993-03-23 1994-09-27 Otsuka Pharmaceut Co Ltd ドライアイ治療剤
EP0637450A3 (en) * 1993-08-04 1995-04-05 Collagen Corp Method and composition for resuscitation of hereditary tissue.
US6013628A (en) * 1994-02-28 2000-01-11 Regents Of The University Of Minnesota Method for treating conditions of the eye using polypeptides

Also Published As

Publication number Publication date
ES2227684T3 (es) 2005-04-01
EP0834320B1 (en) 2004-09-01
ATE274918T1 (de) 2004-09-15
EP0834320A1 (en) 1998-04-08
US6043213A (en) 2000-03-28
DE69730476T2 (de) 2005-11-17
KR100455475B1 (ko) 2004-12-17
NO320601B1 (no) 2005-12-27
DE69730476D1 (de) 2004-10-07
CN1195296A (zh) 1998-10-07
CN1124158C (zh) 2003-10-15
EP0834320A4 (en) 2000-11-22
CA2225398A1 (en) 1997-10-30
NO975962D0 (no) 1997-12-18
JP3058920B2 (ja) 2000-07-04
US6159930A (en) 2000-12-12
WO1997039769A1 (fr) 1997-10-30
CA2225398C (en) 2008-07-15
KR19990028235A (ko) 1999-04-15

Similar Documents

Publication Publication Date Title
NO975962L (no) Legemiddelpreparat som omfatter albumin som aktiv bestanddel
IL153665A0 (en) Topical pharmaceutical formulations and methods of treatment
PT88985A (pt) Processo para a preparacao de composicoes farmaceuticas nasais e ou oftalmicas contendo azelastina
ES2173287T3 (es) Composiciones oticas antibacterianas no irritantes, no sensibilizantes y no ototoxicas.
FI963424A (fi) Menetelmä terapeuttisesti aktiivisten tiofeenisulfonamidien valmistamiseksi
WO2002009702A8 (en) Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
DE69930271T8 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
RU2008102249A (ru) Профилактический или терапевтичесский агент для корнеального /конъюнктивального заболевания
DK0572190T3 (da) Oftalmiske præparater indeholdende vitamin E eller en ester deraf som en aktiv ingrediens
ATE179888T1 (de) Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
EP1074258A3 (en) Methods and compositions for treating diseases and conditions of the eye
ATE337333T1 (de) Ophthalmische arzneimittelzusammenstellung
BR0211970A (pt) Uso de bibn4096 em combinação com outras drogas antienxaqueca para o tratamento de enxaqueca
NO933140D0 (no) Legemiddel for lokal anvendelse paa oeyet for behandling avforhoeyet intraokulart trykk
DK0979652T3 (da) Helbredende præparat til intraokulær hypertension eller glaukom
WO1995034302A3 (en) Method for reducing intraocular pressure in the mammalian eye by administration of calcium chelators
ES2170807T3 (es) Uso de prostaglandinas para la fabricacion de un medicamento para la prevencion y el tratamiento de catarata secundaria.
WO2001028578A3 (en) A PHARMACEUTICAL COMPOSITION CONTAINING pGLU-GLU-PRO-NH2 AND METHOD FOR TREATING DISEASES AND INJURIES TO THE BRAIN, SPINAL CORD AND RETINA USING SAME
BR0114339A (pt) Composições farmaceuticamente aceitáveis contendo epinastina e pseudoefedrina
AU643772B2 (en) Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological use
AU4519289A (en) Medicament for the treatment of cryptosporidiosis
CA2243824A1 (en) Therapeutic agent for keratoconjunctiva diseases
GR3018349T3 (en) Use of naproxen as mydriatic agent.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees